All posts tagged
Do PD-1 and PD-L1 Checkpoint Inhibitors Live Up to Their Hype?
Transgene and BMS Upgrade their Lung Cancer Combination to First Line
Why did Biotech Beat Pharma to Bring the First Gene Therapy to Market?
Will BMS Take Over a Danish Biotech in a Massive €500M Deal?
More News! Will BMS be acquired? “CRISPR babies aren’t unethical”?
French Biotech’s Checkpoint Inhibitor Fails Phase II Leukemia Trial
World Cancer Day is Saturday! Europe’s Oncology in Numbers
A Combination of Checkpoint Inhibitors triggers new Milestone Payment
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
BMS Offers €850M for a British Oncolytic Virus better than CAR-T
Microbiomics recruited for Immuno-Oncology in a Huge New Partnership
Results from 45% of Clinical Trials are kept Secret
Labiotech UG, All Rights Reserved -
Send this to friend